Quick Answer
PALISADE BIO, INC. reported Operating Income of -$18.06 million for fiscal year 2025.
PALISADE BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$18.06M | -21.5% |
| 2024 | -$14.86M | -13.7% |
| 2023 | -$13.07M | +16.9% |
| 2022 | -$15.72M | +62.4% |
| 2021 | -$41.85M | -350.2% |
| 2020 | -$9.30M | -7.7% |
| 2019 | -$8.63M | -4.5% |
| 2018 | -$8.26M | +37.9% |
| 2017 | -$13.31M | +35.5% |
| 2016 | -$20.64M | -7.7% |
| 2015 | -$19.16M | -9.9% |
| 2014 | -$17.44M | -39.2% |
| 2013 | -$12.52M | -23.3% |
| 2012 | -$10.16M | +21.8% |
| 2011 | -$12.99M | +14.5% |
| 2010 | -$15.18M | -45.1% |
| 2009 | -$10.47M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.92M | +18.7% | -2.8% |
| June 30, 2025 | -$2.84M | +32.5% | -23.1% |
| March 31, 2025 | -$2.31M | +37.1% | +35.7% |
| September 30, 2024 | -$3.59M | +4.9% | +14.7% |
| June 30, 2024 | -$4.21M | -16.7% | -14.6% |
| March 31, 2024 | -$3.67M | -45.2% | +2.8% |
| September 30, 2023 | -$3.78M | +14.4% | -4.7% |
| June 30, 2023 | -$3.61M | -1.0% | -42.7% |
- PALISADE BIO, INC. showed a decrease of -21.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, PALISADE BIO, INC.’s operating income has declined by 72.5% (from -$10.47 million to -$18.06 million).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: